2 completed, 1 not yet recruiting. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 2, Not yet recruiting 1 |
Follow Vaxigrip®: new trials by email Literature Review of Vaxigrip® trials Research Report on Vaxigrip®
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase IV Clinical Trial of Influenza Vaccine (Split Virion), Inactivatedin (Anflu®) Pregnant Women (AnFLU-PREG) Anflu®, Vaxigrip® - Influenza | Phase 4 | Not yet recruiting | Sinovac Biotech Co., Ltd | 150 | 2026-10-01 | 2026-09-21 |
| The Immune Response to Influenza Vaccinations in Elderly Individuals Vaxigrip® - Influenza | Phase 4 | Completed | National University Hospital, Singapore | 240 | 2013-12-01 | 2017-08-30 |
| Study of Sanofi Pasteur's Intradermal Influenza Vaccine (IDflu™) in Adults and Elderly in Korea IDflu™: Split virion inactivated influenza vaccine, Vaxigrip®: Split virion inactivated influenza vaccine - Influenza | Phase 4 | Completed | Sanofi Pasteur, a Sanofi Company | 240 | 2010-10-01 | 2018-09-13 |
Influenza, Human (3) · Frailty (1) · Orthomyxoviridae Infections (1) · Respiratory Tract Infections (1)
National University Hospital, Singapore (1) · Sanofi Pasteur, a Sanofi Company (1) · Sinovac Biotech Co., Ltd (1)
China (1) · Singapore (1) · South Korea (1)
Professor Paul Anantharajah Tambyah, MD (1) · Qi Hongbo (1)